Tag: Sanofi

Sanofi suspends production at Mourenx facility due to environmental accusations

French pharma group Sanofi announced an immediate halt in production at a chemical factory in southwest France, in the wake of media reports that toxic waste emissions exceeded the norms.

Kirov pharma cluster participants explored biotech development in France

The delegation of the government of the Kirov region visited the Lyonbiopôle in France, which is largest pharmaceutical cluster in the world.

Sanofi and Advent completed negotiations for the acquisition of Zentiva

Sanofi and Advent International have finished negotiations for the acquisition of Zentiva, Sanofi's European generics business, by Advent and the companies have signed a Share Purchase Agreement worth €1.9 billion

Sanofi sets up its Global R&D Operations Hub in China

Sanofi is launching a Global R&D Operations Hub with a specialized focus on digitalization and big data analysis in Chengdu, Sichuan province, China.

Evotec receives €3 million payment from Sanofi

stem cells
Evotec AG announced that its strategic alliance (TargetBCD) with Sanofi in the field of diabetes has reached its second beta cell therapy milestone, resulting in a payment of €3 million to Evotec.

Evotec and Sanofi join forces to fight infectious diseases

microbiology plates
Evotec signed a transaction agreement with Sanofi to integrate Sanofi’s infectious disease unit into its organisation. Evotec will also licence-in the majority of Sanofi’s infectious disease research portfolio and initiatives.

Sanofi Pasteur and Translate Bio will cooperate on mRNA vaccines

Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, announced a multi-year research and development collaboration and exclusive licensing agreement with Sanofi Pasteur, to develop mRNA vaccines.

Joint efforts to fight diabetes

A Memorandum on Strategic Partnership in the Area of Non-Communicable Diseases was signed between Sanofi; Health of the Nation League, an All-Russian public organization; and Healthy Cities, Districts and Villages Association.

Sanofi will modernize its insulin production facility in Russia

Sanofi announced a new stage in the modernization of its insulin production facility at Sanofi-Aventis Vostok plant in the Orel region as part of the long-term investment strategy in Russia.

Advent International will acquire Sanofi’s generics subsidiary Zentiva

Advent International and Sanofi have entered into exclusive negotiations under which Advent would acquire Zentiva, Sanofi’s European generics business for €1,919 million.

Sanofi will pump €350 million into construction of its new Canadian facility

Sanofi, a leading global pharmaceutical company, is investing €350 million for the construction of a new state-of-the-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario.

Evotec and Sanofi will create a new innovation platform in France

test tube
Evotec AG and Sanofi have entered into exclusive negotiations for Evotec to accelerate infectious disease research and development through a new open innovation platform near Lyon, France.

WHO approved Shantha Biotechnics cholera vaccine

Shantha Biotechnics, an affiliate of Sanofi Pasteur, has received approval from the World Health Organisation (WHO) for Shanchol, its oral cholera vaccine. The approval is for use at temperatures as h...

Sanofi licenses universal influenza vaccine technology from SK Chemicals

SK Chemicals Co., a South Korean vaccine maker, signed $155 million deal to license cell culture technology to Sanofi Pasteur Inc. for development of a universal influenza vaccine

Sanofi acquires a Belgian biopharmaceutical company

Sanofi and Ablynx, a biopharmaceutical company engaged in development of Nanobodies, entered into a definitive agreement under which Sanofi will offer to acquire Ablynx at a price of approximately €3.9 billion

Sanofi buys Bioverativ biopharmaceutical company

Sanofi and Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia, have entered into a agreement under which Sanofi will acquire all of the outstanding shares of Bioverativ